Delving into the Latest Updates on Ineos Healthcare Ltd. with Synapse

Overview

Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb.
The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in subjects requiring haemodialysis, compared with a marketed phosphate binder, sevelamer hydrochloride.

Start Date01 Jul 2009

Sponsor / Collaborator

Ineos Healthcare Ltd.

NCT00841126

/ TerminatedPhase 3

An Open, Randomized, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate Together With a Randomized Placebo Controlled Double Blind Fermagate Comparison in Hemodialysis Patients With Hyperphosphatemia

Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb.
The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in subjects requiring hemodialysis, compared with a marketed phosphate binder, lanthanum carbonate and placebo.

Start Date01 Jul 2009

Sponsor / Collaborator

Ineos Healthcare Ltd.

100 Clinical Results associated with Ineos Healthcare Ltd.

Login to view more data

0 Patents (Medical) associated with Ineos Healthcare Ltd.

Login to view more data

100 Deals associated with Ineos Healthcare Ltd.

Login to view more data

100 Translational Medicine associated with Ineos Healthcare Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

3

Login to view more data